SFA Therapeutics
SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.
1
Funding Rounds
$4.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ir* Sp***** |
|
- | |
| Ma** Fe******* |
|
- | linkedin twitter |
| Al** Ar******** |
|
- |
Industries
SFA Therapeutics is active in the following industries: